Advanced breast cancer patients treated with oral vinorelbine: a prospective and retrospective, observational study – VINOREAL

It is not common practice to reappraise drugs that have been available for many years. Oral vinorelbine tartrate (OV) is a widely used treatment for ABC, with a very good toxicity profile. There are currently few recent studies supporting the effectiveness of OV in a real-life setting. It would therefore be beneficial to document and reassess the effectiveness and safety profile of OV in monotherapy or in combination with other medications (OV-based treatment) in routine practice. 

To achieve this goal, we will be looking at the results from two groups of patients (also called here cohort): those who have already been treated (in the retrospective study part) and those who are currently being treated or will be in the future (in the prospective study part).